A modernized ART for Illumina read simulation.

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Running an obsolete OS, on obsolete hardware, configured with obsolete settings. A widely used DNA sequencer contains several worrying vulnerabilities. The Illumina iSeq 100 can be “easily” disabled ...

What's it like to build the software in a brand-new sequencer? Illumina's Aneesh Natarajan takes us on the journey Originally published on Illumina News Center NORTHAMPTON, MA / ACCESS Newswire ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech ...

BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable devices used for detecting illnesses and developing vaccines.

Recent reports highlight a critical security flaw in Illumina’s iSeq 100 DNA sequencer, raising serious concerns about the safety of patient data and the integrity of genetic research. The post ...

A collection of publications on comparison of high-throughput sequencing technologies.

Eclypsium security researchers have uncovered UEFI vulnerabilities in the Illumina iSeq 100 DNA sequencer, but the broader issue involves the device development process at large. In highlighting ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.